Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05934773 · ClinicalTrials.gov registry record · NA

Post-Brain Injury Walking and Balance Recovery Program

A NA study, sponsored by The University of Texas Medical Branch, Galveston.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT05934773: Clinical Trial NA study, sponsored by The University of Texas Medical Branch, Galveston.

NCT05934773 is a NA study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05934773, a NA study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The purpose of this study is to test the efficacy of a walking and balance training program designed to safely challenge and improve walking performance and balance in relation to walking speed, strength, endurance, and balance after traumatic brain injury (TBI). The aim and primary hypothesis of this research project is: Aim) Test and implement a new personalized intervention strategy, in addition to usual and customary care at an inpatient rehabilitation clinic, to improve patient outcomes with secondary conditions associated with impaired balance and walking that typically occur post brain injury. After validation of the locomotor Battery of tests, we will implement a personalized training strategy for individuals based on their battery profile. Hypothesis) Individuals training with this individualized protocol will demonstrate improved walking and balance outcomes and those with lesser pre-intervention impairment will improve at a greater rate than those with greater pre-intervention impairment.

Primary Outcome

The 10 Meter Walk Test is a performance measure used to assess walking speed in meters per second over a short distance

Interventions

  • DEVICE KineAssist robotic treadmill

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2022-08-18
Est. Completion 2025-04-04
Phase NA

Why NCT05934773 stopped before completion

NCT05934773 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which KineAssist robotic treadmill is the first listed.

NCT05934773 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05934773 about?

NCT05934773 is a clinical study titled "Post-Brain Injury Walking and Balance Recovery Program". The purpose of this study is to test the efficacy of a walking and balance training program designed to safely challenge and improve walking performance and balance in relation to walking speed, strength, endurance, and balance after traumatic brain injury (TBI). The aim and primary hypothesis of t...

What is the current status of trial NCT05934773?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2022-08-18. Estimated completion is 2025-04-04.

What interventions are being tested in trial NCT05934773?

The interventions under investigation include: KineAssist robotic treadmill (DEVICE).

Who is sponsoring clinical trial NCT05934773?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05934773's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05934773, the US trial registry maintained by the National Library of Medicine. NCT05934773 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.